Shares of RiceBran Technologies (NASDAQ:RIBT) have received a consensus broker rating score of 3.00 (Hold) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold rating.
Zacks has also assigned RiceBran Technologies an industry rank of 162 out of 256 based on the ratings given to its competitors.
Several institutional investors have recently modified their holdings of RIBT. Creative Planning purchased a new position in shares of RiceBran Technologies in the 1st quarter worth approximately $41,000. Deutsche Bank AG grew its position in shares of RiceBran Technologies by 393.1% in the 4th quarter. Deutsche Bank AG now owns 35,500 shares of the company’s stock worth $106,000 after buying an additional 28,300 shares during the last quarter. Wedbush Securities Inc. purchased a new position in shares of RiceBran Technologies in the 1st quarter worth approximately $372,000. Dimensional Fund Advisors LP grew its position in shares of RiceBran Technologies by 33.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 160,555 shares of the company’s stock worth $482,000 after buying an additional 40,215 shares during the last quarter. Finally, Continental Grain Co. grew its position in shares of RiceBran Technologies by 11.9% in the 1st quarter. Continental Grain Co. now owns 6,279,702 shares of the company’s stock worth $23,361,000 after buying an additional 666,667 shares during the last quarter. 29.86% of the stock is currently owned by hedge funds and other institutional investors.
RiceBran Technologies (NASDAQ:RIBT) last issued its quarterly earnings data on Thursday, May 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.03). RiceBran Technologies had a negative return on equity of 38.80% and a negative net margin of 53.57%. The firm had revenue of $6.36 million during the quarter.
RiceBran Technologies Company Profile
RiceBran Technologies processes and markets healthy, natural, and nutrient dense products derived from raw rice bran. The company manufactures and distributes stabilized rice bran (SRB) in various granulations with other products and derivatives. It offers RiBalance, a rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich derivative of RiBalance; and protein and protein/fiber blends under the ProRyza brand.
Further Reading: Death Cross
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for RiceBran Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RiceBran Technologies and related companies with MarketBeat.com's FREE daily email newsletter.